Publication | Closed Access

Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study in Locally Advanced Rectal Cancer

Radiation MedicineRadiation TherapyGastrointestinal OncologyMedicineNeoadjuvant TreatmentPhase Ii StudySingle-agent Cetuximab FollowedCancer TreatmentOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences